CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

Regulatory Watchboard

8 events

Sep 2024Blinatumomab for CNI-Resistant/Intolerant SRNS in Children

The Children's Hospital of Zhejiang University School of Medicine — PHASE1

TrialRECRUITING

Aug 2024Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch

University Hospital, Antwerp — PHASE4

TrialRECRUITING

Jun 2024Botox Versus Tacrolimus in Psoriasis Vulgaris

Assiut University — PHASE4

TrialNOT YET RECRUITING

Mar 2024Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

University of Chicago — PHASE1, PHASE2

TrialRECRUITING

Dec 2023Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

National Institute of Allergy and Infectious Diseases (NIAID) — PHASE2

TrialRECRUITING

Nov 2022The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

National Cancer Institute (NCI) — PHASE1, PHASE2

TrialRECRUITING

Jul 2022Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)

Université de Sherbrooke — PHASE2

TrialACTIVE NOT RECRUITING

Jul 2021A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Bristol-Myers Squibb — PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome.
Search all trials →

Search clinical trials for CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome →

Recent News & Research

No recent news articles indexed yet for CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome.
Search PubMed for CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome →

Browse all CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome news →

Specialist Network

Top 2 by expertise

Use Central Contact

Astellas Pharma Inc

Score 628 trials

Leslie Kean, MD, PhD, MD/PhD

Boston Children's Hospital

📍 BOSTON, MA

Score 42 trials

View all CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles